Biologics are some of the newest treatment options for atopic dermatitis. Biologics have been around for years as treatment options for many conditions that affect the immune system, but the FDA ...

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...

It can be hard to tell for sure if you have atopic dermatitis, also known as eczema ... Find out which eczema treatment is right for you. If your eczema is severe, your doctor might recommend ...

Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose.

Discover expert methods to identify, treat and prevent various types of skin rashes, from allergic reactions to chronic ...

The FDA has accepted the supplemental new drug application for Zoryve cream 0.05% to treat mild to moderate atopic dermatitis ...

Topical roflumilast, 0.05%, is under consideration for treating mild to moderate atopic dermatitis in children aged 2-5 years ...

The FDA has cleared an Investigational New Drug Application for Zabalafin Hydrogel, a multi-target therapy for mild to ...

Orismilast may be an effective and safe novel treatment option for adult patients with moderate to severe atopic dermatitis.

A global cohort study reveals that dupilumab offers a superior cardiometabolic safety profile for atopic dermatitis patients ...

This once-daily topical treatment is the latest phosphodiesterase-4 (PDE4) inhibitor designed for mild to moderate atopic ...

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...